For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician's programmer, Patient's programmer.
Scope of the Report:
In the last several years, United States market of Implantable Neurostimulators developed rapidly, with an average growth rate of 11%. In 2015, United States capacity of Implantable Neurostimulators is nearly 169 k units, the actual production is about 130 k units, and local sales are about 87 k units.
Minnesota region is the largest supplier of Implantable Neurostimulators, with a production market share nearly 39%. Massachusetts is the second largest supplier of Implantable Neurostimulators, enjoying production market share nearly 18%.
South Atlantic is the largest consumption place, with a consumption market share nearly 23%. Following South Atlantic, Mid-Atlantic Region is the second largest consumption place with the consumption market share of 20%.
The worldwide market for Implantable Neurostimulators is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Implantable Neurostimulators in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Medtronic
- Boston Scientific
- St. Jude Medical
- Cyberonics
- NeuroPace
- Synapse Biomedical
- NeuroSigma
- EnteroMedics
- ElectroCore Medical
- Inspire Medical
- NEUROS
- SPR
- IMTHERA
- NEVRO
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Vagal Nerve Stimulators
- Sacral Nerve Stimulators
- Gastric Stimulators
- Others
Market Segment by Applications, can be divided into
- Parkinson's Disease
- Epilepsy
- Pain
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Implantable Neurostimulators product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Implantable Neurostimulators, with price, sales, revenue and global market share of Implantable Neurostimulators in 2017 and 2018.
Chapter 3, the Implantable Neurostimulators competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implantable Neurostimulators breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Implantable Neurostimulators market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Implantable Neurostimulators sales channel, distributors, customers, research findings and conclusion, appendix and data source.